Rafferty Asset Management
CABA icon

Rafferty Asset Management’s Cabaletta Bio CABA Stock Holding History

Rafferty Asset Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$454K Buy
+146,107
New +$481K ﹤0.01% 915
2024
Q3 		– Sell
-103,582
Closed -$775K – 1151
2024
Q2 		$775K Sell
103,582
-250,842
-71% -$3.07M ﹤0.01% 864
2024
Q1 		$6.05M Buy
354,424
+145,161
+69% +$3.12M 0.02% 430
2023
Q4 		$4.75M Buy
209,263
+91,113
+77% +$1.53M 0.02% 453
2023
Q3 		$1.8M Buy
+118,150
New +$1.61M 0.01% 638

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Rafferty Asset Management's CABA Position: Q2 2026 in Review

Rafferty Asset Management opened a new position in Cabaletta Bio (CABA) in Q2 2026: 146,107 shares worth $454K. The stake represents ﹤0.01% of the portfolio and ranks #915 among its holdings. This is a return to the name: Rafferty Asset Management previously reported a position in CABA as recently as Q2 2024.

Rafferty Asset Management first reported a position in CABA in Q3 2023 and has held it in 5 quarters since. The position peaked at $6.05M in Q1 2024. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Rafferty Asset Management held 146,107 shares of Cabaletta Bio worth $454K as of Q2 2026.
  • Cabaletta Bio was a new Rafferty Asset Management position in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #915 holding.
  • Rafferty Asset Management first reported a position in Cabaletta Bio in Q3 2023 and has held it in 5 quarters since.
  • Rafferty Asset Management's Cabaletta Bio position peaked at $6.05M in Q1 2024.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.